Nontuberculous mycobacterial infections

Annals of Pharmacotherapy

Volumn 30, Issue 7-8, 1996, Pages 819-830

  Guay, David R P ^a,b  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOSALICYLIC ACID; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; CEFOXITIN; CILASTATIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; DOXYCYCLINE; ETHAMBUTOL; IMIPENEM; ISONIAZID; MACROLIDE; MINOCYCLINE; OFLOXACIN; PROBENECID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TUBERCULIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; DRUG CHOICE; DRUG MIXTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG DISEASE; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM SMEGMATIS; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; TUBERCULIN TEST;

EID: 0030037382     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000721     Document Type: Review

References (199)

1. Peloquin CA. Mycobacterial infections. Pharmacotherapy 1993;13:634-9.
2. Porter JD, McAdam KP. The re-emergence of tuberculosis. Annu Rev Public Health 1994;15:303-23.
3. Peloquin CA, Berning SE. Infection caused by Mycobacterium tuberculosis. Ann Pharmacother 1994;28:72-84.
4. Iseman MD. Treatment of multi drug-resistant tuberculosis. N Engl J Med 1993;329:784-91.
5. Grange JM. Diagnostic tests for tuberculosis and their evaluation. Semin Respir Infect 1994;9:71-7.
6. O'Brien RJ. Drug-resistant tuberculosis: etiology, management and prevention. Semin Respir Infect 1994;9:104-12.
7. Collins FM. Tuberculosis: the return of an old enemy. Crit Rev Microbiol 1993;19:1-16.
8. Woods GL. Disease due to the Mycobacterium avium complex in patients infected with human immunodeficiency virus: diagnosis and susceptibility testing. Clin Infect Dis 1994;18(suppl 3):S227-32.
9. Peloquin CA. Controversies in the management of Mycobacterium avium complex infection in AIDS patients. Ann Pharmacother 1993;27:928-37.
10. Inderlied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
11. Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994; 18(suppl3):S218-22.
12. Shinnick TM, Good RC. Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis 1994;13:884-901.
13. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Seabury Stone M. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.
14. Wheeler AP, Graham BS. Atypical mycobacterial infections. South Med J 1989;82:1250-8.
15. Smith MJ, Citron KM. Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax 1983;83:373-7.
16. Wolinsky E. Nontuberculosis mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59.
17. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990;142:940-53.
18. Brennan PJ. Structures of the typing antigens of atypical mycobacteria: a brief review of present knowledge. Rev Infect Dis 1981;3:905-13.
19. Inderlied CB. Antimycobacterial susceptibility testing: present practices and future trends. Eur J Clin Microbiol Infect Dis 1994;13:980-93.
20. Moran JF, Alexander LG, Staub EW, Young WG Jr, Sealy WC. Long-term result of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg 1983;35:597-604.
21. Sigalet D, Lees G, Fanning A. Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J Pediatr Surg 1992;11: 1381-4.
22. Stewart MG, Starke JR, Coker NJ. Nontuberculous mycobacterial infections of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120: 873-6.
23. Dhooge I, Dhooge C, DeBaets F, Van Cauwenberge P. Diagnostic and therapeutic management of atypical mycobacterial infections in children. Eur Arch Otorhinolaryngol 1993;250:387-91.
24. Wallace RJ Jr. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994;13:953-60.
25. DaCosta Cruz J. Mycobacterium fortuitum, un novo bacilo acido resistente patogenico par ó homen. Acta Med Rió de Janiero 1938;1:297-301.
26. Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous abscess-like lesions of the gluteal region. J Invest Dermatol 1953;20:133-69.
27. Wallace RJ Jr, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA. Human disease due to Mycobacterium smegmatis. J Infect Dis 1988;158: 52-9.
28. White R, Abreo K, Flanagan R, Godallah M, Krane K, El-Shahawy M, et al. Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1993;22:581-7.
29. Subbarao EK, Tarpay MM, Marks MI. Soft-tissue infections caused by Mycobacteriumfortuitum complex following penetrating injury. Am J Dis Child 1987;141:1018-20.
30. Borghans JGA, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973;107:1-8.
31. Lowry PW, Jarvis WR, Oberle AD, Bland LA, Silberman R, Bocchini JA Jr, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med 1988;319:978-82.
32. Wallace RJ Jr. Diagnostic and therapeutic consideration in patients with pulmonary disease due to the rapidly growing mycobacteria. Semin Respir Med 1986;1:230-3.
33. Neitch SM, Sydnor JB, Schleupner CJ. Mycobacteriumfortuitum as a cause of mastoiditis and wound infection. Arch Otolaryngol 1982;108: 11-4.
34. Horsburgh CR Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immune deficiency syndrome (AIDS). Am Rev Respir Dis 1989;139:4-7.
35. Hoy JF, Rolston KV, Hopfer RL, Bodey GP. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med 1987;83:213-7.
36. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13:1120-5.
37. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-71.
38. Robicsek F, Daugherty HK, Cook JW, Selle JG, Masters TN, O'Bar PR, et al. Mycobacterium fortuitum epidemics after open-heart surgery. J Thorac Cardiovasc Surg 1978;75:91-6.
39. Levy C, Curtin JA, Watkins A, Marsh B, Garcia J, Mispereta L. Mycobacterium chelonei infection of porcine heart valves. N Engl J Med 1977297:667-8.
40. Laskowski LF, Marr JJ, Spemoga JF, Frank NJ, Barner HB, Kaiser G, et al. Fastidious mycobacteria grown from prosthetic-heart-valve cultures. N Engl J Med 1977;297:101-2.
41. Viscidi R, Geller A, Caplan W, Natsios GA, Gleckman RA. Prosthetic valve endocarditis caused by Mycobacterium chelonei: case report and literature review. Heart Lung 1982;11:555-9.
42. Inman PM, Beck A, Brown AE, Stanford JL. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969;100:141-7.
43. Band JD, Ward JI, Fraser W, Peterson NJ, Silcox VA, Good RC, et al. Peritonitis due to a Mycobacterium chelonae-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982;145:9-17.
44. Wallace RJ Jr, Silcox VA, Tsukamura M, Brown BA, Kilburn JO, Butler WR, et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol 1993;31:3231-9.
45. Wallace RJ Jr, Brown BA, Silcox VA, Tsukamura M, Nash DR, Steele LC, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis 1991;163:598-603.
46. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-8.
47. Griffith DE, Wallace RJ Jr. Pulmonary disease due to rapidly growing mycobacteria. Semin Respir Med 1988;9:505-13.
48. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992;166:405-12.
49. Hoffman PC, Fraser DW, Robicsek F, O'Bar PR, Mauney CU. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981;143:533-42.
50. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938-9.
51. Clegg HW, Foster MT, Sanders WE, Baine WB. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983;147: 427-33.
52. Wallace RJ Jr, Steele JC, Labidi A, Silcox VA. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J Infect Dis 1989;160:281-8.
53. Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, Wallace RJ Jr. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis 1992;145:853-5.
54. Gubler JGH, Salfinger M, von Graevenitz A. Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine: report of an outbreak and review of the literature. Chest 1992; 101:1245-9.
55. Nye K, Chadha DK, Hodgkin P, Bradley C, Hancox J, Wise R. Mycobacierium chelonae isolation from broncho-alveolar lavage fluid and its practical implications. J Hosp Infect 1990;16:257-61.
56. Bolan G, Reingold A, Carson LA, Silcox VA, Woodley CL, Hayes PS, et al. Infections with Mycobacterium chelonae in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 1985;152:1013-9.
57. Laussucq S, Balten AL, Smith RP, Smithwick RW, Davis BJ, Desjardin EK, et al. Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. Am Rev Respir Dis 1988;138:891-4.
58. Brown TH. The rapidly growing mycobacteria - Mycobacterium fortuitum and Mycobacterium chelonei. Infect Control 1985;6:283-8.
59. Swenson JM, Thornsberry C, Silcox VA. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982;22:186-92.
60. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985;28:807-11.
61. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991;35:773-5.
62. Van Caekenberghe D. Comparative in vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp. J Antimicrob Chemother 1990;26:381-6.
63. Wallace RJ Jr, Bedsole G, Sumter G, Sanders CV, Steele LC, Brown BA, et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990;34:65-70.
64. Brown BA, Wallace RJ Jr, Onyi GO, DeRosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-4.
65. Wallace RJ Jr, Dalovisio JR, Pankey GA. Disk diffusion testing of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother 1979;16:611-4.
66. Berlin OG, Young LD, Floyd-Reising SA, Bruckner DA. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria. Eur J Clin Microbiol 1987;6:486-7.
67. Yew WW, Kwan SL, Ma WK, Lui KS, Aung MK. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from post-operative wounds. Clin Ther 1989;11:775-85.
68. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of non-pulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonae on the basis of in vitro susceptibilities. J Infect Dis 1985; 152:500-14.
69. Yew WW, Kwan SYL, Ma WK, Aung-Khin M, Mok CK. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection. Chest 1989;95:1051-5.
70. Yew WW, Kwan SYL, Wong PC, Lee J. Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections. Tubercle 1990;71:131-3.
71. Lederer J, Warner W, Leggiadro RJ. Clarithromycin treatment of post-traumatic Mycobacterium fortuitum wound infection. Pediatr Infect Dis J 1993;12:697-8.
72. Yew WW, Lau KS, Tse WK, Wong CF. Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience. Clin Infect Dis 1992;15:1046-7.
73. Dalovisio JR, Pankey GA, Wallace RJ Jr, Jones DB. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981;3:1068-74.
74. Zahid MA, Klotz SA, Goldstein E, Bartholomew W. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin Infect Dis 1994;18:999-1001.
75. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-6.
76. Franck N, Cabie A, Villette B, Amor B, Lessana-Leibowitch M, Escande JP. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 1993;28:1019-21.
77. Plaus WJ, Hermann G. The surgical management of superficial infections caused by atypical mycobacteria. Surgery 1991;110:99-103.
78. Moerman M, Dierick J, Mestdagh J, Boedts D, Van Cauwenberge P. Mastoidilis caused by atypical mycobacteria. Int J Pediatr Otorhinolaryngol 1993;28:69-76.
79. Hwang DG, Biswell R. Ciprofloxacin therapy of Mycobacterium chelonae keratins. Am J Ophthalmol 1993;115:114-5.
80. Grigg J, Hirst LW, Whitby M, Stallard K, Gnanaharan P. Atypical Mycobacterium keratitis. Aust N Z J Ophthalmol 1992;20:257-61.
81. Broadway DC, Ken-Muir MG, Eykyn SJ, Pambakian H. Mycobacterium chelonei keratitis: a case report and review of previously reported cases. Eye 1994;8:134-42.
82. Boltger EC. Mycobacterium genavense: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1994;13:932-6.
83. Wald A, Coyle MB, Carlson LC, Thompson RL, Hooton TM. Infection with a fastidious Mycobacterium resembling Mycobacterium simiae in seven patients with AIDS. Ann Intern Med 1992;117:586-9.
84. Nadal D, Cadulff R, Kraft P, Salfinger M, Bodmer T, Kirschner P, et al. Invasive infection with Mycobacterium genavense in children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis 1993;12:5-11.
85. Bessesen MT, Shlay J, Stone-Venohr B, Cohn DL, Reves RR. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 1993;7:1357-61.
86. Coyle MB, Carlson LC, Wallis CK, Leonard RB, Raisys VA, Kilburn JD, et al. Labortory aspects of Mycobacterium genavense, a proposed species from AIDS patients. J Clin Microbiol 1992;30:3206-12.
87. Hoop RK, Böttger EC, Ossent P, Salfinger M. Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol 1993;31: 990-3.
88. Maschek HJ, Georgii A, Schmidt RE, Kirschner P, Böttger EC. Mycobacterium genavense: autopsy findings in three patients. Am J Clin Pathol 1994;101:95-9.
89. London RD, Dumsker B, Neibart EP, Knorr B, Bottone EJ. Mycobacterium gordonae: an unusual peritoneal pathogen in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med 1988;85:703-4.
90. Zola L, Hunziker T, Braathen LR. Chronic cutaneous infection caused by Mycobaclerium gordonae. Dermatology 1993;187:301-2.
91. Kurnik PB, Padmanabh U, Bonatsos C, Cynamon MH. Mycobacterium gordonae as a human hepato-peritoneal pathogen, with a review of the literature. Am J Med Sci 1983;285:45-8.
92. Weinberger M, Berg SL, Feuerstein IM, Pizzo PA, Witebsky FG. Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature. Clin Infect Dis 1992;14:1229-39.
93. Turner DM, Ramsey PG, Ojemann DA, Ralph DD. Disseminated Mycobacterium gordonae infection associated with glomerulonephritis. West J Med 1985;142:391-3.
94. Lessnau K-D, Milanese S, Talavera W. Mycobacterium gordonae: a treatable disease in HIV-positive patients. Chest 1993;104:1779-85.
95. Marchevsky A, Damsker B, Gribetz A, Tepper S, Geller SA. The spectrum of pathology of nontuberculous mycobacterial infections in open-lung biopsy specimens. Am J Clin Pathol 1982;78:695-700.
96. Garcia-Forcada A, Garces JM, Berges A, Coll J. Infeccion pulmonar por Mycobacterium gordonae y pneumonia por Pneumocystis carinii en un paciente afecto de sindrome de immunodeficiencia adquirida. Med Clin 1991;13:518-9.
97. Chan J, McKitrick JC, Klein RS. Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:400.
98. Barber TW, Craven DE, Farber HW. Mycobaclerium gordonae: a possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection. Chest 1991;100:716-20.
99. Gangadharam PRJ, Lockhart JA, Awe RJ, Jenkins DE. Mycobacterial contamination through tap water. Am Rev Respir Dis 1976;113:894.
100. Panwalker AP, Fuhse E. Nosocomial M. gordonae pseudoinfection from contaminated ice machines. Infect Control 1986;7:67-70.
101. Steere AC, Corrales J, von Graevenitz A. A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Am Rev Respir Dis 1979;120:214-6.
102. Tokars JI, McNeil MM, Tablan OC, Chapin-Robertson K, Patterson JE, Edberg SC, et al. Mycobacterium gordonae pseudoinfection associated with a contaminated antimicrobial solution. J Clin Microbiol 1990;28:2765-9.
103. Dautzenberg B, Truffot C, Mignon A, Rozenbaum W, Katlama C, Perronne C, et al. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunistic mycobacteria. Tubercle 1991;72:168-75.
104. Sompolinsky D, Lagziel A, Naveh D, Yankilevitz T. Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J System Bacteriol 1978;28:67-75.
105. Kiehn TE, White M. Mycobacterium haemophilum: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1994;13:925-31.
106. Abbott MR, Smith DD. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice. J Med Microbiol 1980;13:535-40.
107. Davis BR, Brumbach J, Sanders WJ, Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 1982;97:723-4.
108. Males BM, West TE, Bartholomew WR. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome. J Clin Microbiol 1987;25:186-90.
109. Gouby A, Branger B, Oules R, Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal dialysis unit. J Med Microbiol 1988;25:299-300.
110. Rogers PL, Walker RE, Lane HC, Witebsky FG, Kovacs JA, Parrillo JE, et al. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med 1988;84:640-2.
111. McBride ME, Rudolph AH, Tschen JA, Cernoch P, Davis J, Brown BA, et al. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch Dermatol 1991;127:276-7.
112. Kristjansson M, Bieluch VM, Byeff PD. Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature. Rev Infect Dis 1991;13:906-10.
113. Armstrong KL, James RW, Dawson DJ, Francis PW, Masters B. Mycobacterium haemophilum causing peri-hilar or cervical lymphadenitis in healthy children. J Pediatr 1992;121:202-5.
114. Dever LL, Martin JW, Seaworth B, Jorgensen JH. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis 1992;14:1195-200.
115. Straus WL, Ostroff SM, Jernigan DB, Kiehn TE, Sordillo EM, Armstrong D, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994;120:118-25.
116. Gupta I, Kocher J, Miller AJ, Weisholtz SJ, Perz J, Scully M. Mycobacterium haemophilum osteomyelitis in an AIDS patient. N J Med 1992; 89:201-2.
117. Bernard EM, Edwards FF, Kiehn TE, Brown ST, Armstrong D. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother 1993;37:2323-6.
118. Francis PB, Jay SJ, Johanson WG Jr. The course of untreated Mycobacterium kansasii disease. Am Rev Respir Dis 1975;111:477-87.
119. Maniar AC, Vanbuckenhout LR. Mycobacterium kansasii from an environmental source. Can J Public Health 1976;67:59-60.
120. Research Committee of the British Thoracic and Tuberculosis Association. Opportunist mycobacterial pulmonary infection and occupational dust exposure: an investigation in England and Wales. Tubercle 1975; 56:295-310.
121. Nylen O, Alestig K, Fasth A, Gustavii N, Olafsson J, Renvall U, et al. Infections of the ear with nontuberculous mycobacteria in three children. Pediatr Infect Dis J 1994;13:653-6.
122. Rigsby MO, Curtis AM. Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus. Chest 1994;106:913-9.
123. Bergen GA, Yangco BG, Adelman HM. Central nervous system infection with Mycobacterium kansasii (letter). Ann Intern Med 1993;118: 396.
124. Glickstein SL, Nashel DJ. Mycobacterium kansasii septic arthritis complicating rheumatic disease: case report and review of the literature. Semin Arth Rheum 1987;16:231-5.
125. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976;136:67-70.
126. Gorse GJ, Fairshter RD, Friedly G, Del Maza L, Greene GR, Cesario TC. Nontuberculous mycobacterial disease: experience in a southern California hospital. Arch Intern Med 1983;143:225-8.
127. Rolston KVI, Jones PG, Fainstein V, Bodey GP. Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer. Chest 1985;87:503-6.
128. Lillo M, Orengo S, Cernoch P, Harris PL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990;12:760-7.
129. Levine B, Chiasson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:861-8.
130. Bamberger DM, Driks MR, Gupta MR, O'Connor MC, Jost PM, Neihart RE, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994; 18:395-400.
131. Buhler VB, Pollack A. Human infection with atypical acid-fast organisms: report of two cases with pathologic findings. Am J Clin Pathol 1953;23:363-74.
132. Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829-33.
133. Kubin M, Svandova E, Medek B, Chobot S, Ilsovsky Z. Mycobacterium kansasii infections in an endemic area of Czechoslovakia. Tubercle 1980;61:207-12.
134. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax 1983;38:271-4.
135. Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988; 137:149-52.
136. Hjelm U, Kaustova J, Kubin M, Hoffner SE. Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur J Clin Microbiol Infect Dis 1992;11:51-4.
137. Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverblatt J. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev Infect Dis 1981;3:1035-9.
138. Ahn CH, Lowell JR, Ahn SA, Ahn S, Hurst GA. Chemotherapy for pulmonary disease due to Mycobactenum kansasii: efficacies of some individual drugs. Rev Infect Dis 1981;3:1028-34.
139. Research Committee of the British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994;49: 442-5.
140. Ahn CH, Wallace RJ Jr, Steele LC, Murphy DT. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobactenum kansasii. Am Rev Respir Dis 1987;135:10-6.
141. Wallace RJ Jr, Durbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, et al. Rifampin-resistant Mycobactenum kansasii. Clin Infect Dis 1994; 18:73643.
142. Hoffner SE. Pulmonary infections caused by less frequently encountered slow-growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994;13:937-41.
143. Warren NG, Body BA, Silcox VA, Matthews JH. Pulmonary disease due to Mycobacterium malmoense. J Clin Microbiol 1984;20:245-7.
144. Banks J, Jenkins PA, Smith AP. Pulmonary infection with Mycobactenum malmoense - a review of treatment and response. Tubercle 1985;66:197-203.
145. Alberts M, Chandler KW, Soloman DA, Goldman AL. Pulmonary disease caused by Mycobactenum malmoense. Am Rev Respir Dis 1987; 135:1375-8.
146. Jenkins PA. Mycobacterium malmoense. Tuber Lung Dis 1985;66:193-5.
147. Henriques B, Hoffner SE, Petrini B, Juhlin I, Wåhlen P, Källenius G. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994;18:596-600.
148. Portaels F, Denef M, Larsson L. Pulmonary disease caused by Mycobacterium malmoense: comments on the possible origin of infection and methods for laboratory diagnosis. Tubercle 1991;72:218-22.
149. Zaugg M, Salfinger M, Opravil M, Luthy R. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review. Clin Infect Dis 1993;16:540-9.
150. Engervall P, Björkholm M, Petrini B, Heurlin N, Henriques B, Källenius G. Disseminated Mycobacterium malmoense infection in a patient with chronic granulocytic leukaemia, J Intern Med 1993;234:231-3.
151. Schröder KH, Juhlin I. Mycobacterium malmoense sp. nov. Int J System Bacteriol 1977;27:241-6.
152. Evans AJ, Crisp AJ, Colville A, Evans SA, Johnston IDA. Pulmonary infections caused by Mycobacterium malmoense and Mycobacterium tuberculosis: comparison of radiographic features. AJR Am J Roentgenol 1993;161:733-7.
153. Hoffner SE, Hjelm U, Källenius G. Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrob Agents Chemother 1993;37:1285-8.
154. Ellis ME. Mycobacteria other than Mycobacterium tuberculosis. Curr Opin Infect Dis 1988;1:252-71.
155. Philpott JA Jr, Woodburne AR, Philpott OS, Schaefer WB, Mollohan CS. Swimming pool granuloma: a study of 290 cases. Arch Dermatol 1963;88:158-62.
156. Collins CH, Grange JM, Noble WC, Yates MD. Mycobacterium marmum infections in man. J Hyg Camb 1985;94:135-49.
157. Edelstein H. Mycobacterium marinum skin infections: report of 31 cases and review of the literature. Arch Intern Med 1994;154:1359-64.
158. Winter FE, Runyon EH. Prepatellar bursitis caused by Mycobacterium marinum (balnei): case report, classification, and review of the literature. J Bone Joint Surg 1965;47A:375-9.
159. Jolly HW, Seabury JH, Infections with Mycobacterium marinum. Arch Dermatol 1972;106:32-6.
160. Cortez LM, Pankey GA. Mycobacterium marinum infections of the hand: report of three cases and review of the literature. J Bone Joint Surg 1973;55A:363-70.
161. Littlejohn GO, Dixon PL. Fish fanciers finger. J Rheumatol 1984;11: 390-1.
162. Gray SF, Smith RS, Reynolds NJ, Williams EW. Fish tank granuloma. BMJ 1990;300:1069-70.
163. Williams CS, Riordan DC. Mycobacterium marinum (atypical acid fast bacillus) infections of the hand. J Bone Joint Surg 1973;55A:1042-50.
164. Even-Paz Z, Haas H, Sacks T, Rosenmann E. Mycobacterium marinum skin infections mimicking cutaneous leishmaniasis. Br J Dermatol 1976;94:43542.
165. Johnston JM, Izumi AK. Cutaneous Mycobacterium marinum infection ("swimming pool granuloma"). Clin Dermatol 1987;5(3):68-75.
166. Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993;118:883-8.
167. Wallace RJ Jr, Wiss K, Bushby MB, Hollowell DC. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. Rev Infect Dis 1982;4:326-31.
168. Torres JR, Sands M, Sanders C. In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle 1988;59:193-5.
169. Izumi AK, Hanke W, Higaki M. Mycobacterium marinum: infections treated with tetracycline. Arch Dermatol 1977;113:1067-8.
170. Iredell J, Whitby M, Blacklock Z. Mycobacterium marinum infection: epidemiology and presentation in Queensland 1971-1990. Med J Aust 1992;157:596-8.
171. Donta ST, Smith PW, Levitz RE, Quintiliani R. Therapy of Mycobacterium marinum infections: use of tetracyclines vs. rifampin. Arch Intern Med 1986;146:902-4.
172. Hanke CW, Bergfeld WF, Shear H. Sporotrichoid Mycobacterium marmum skin infection treated with minocycline hydrochloride. Cleve Clin Q 1980;47:339-42.
173. Loria PR. Minocycline hydrochloride treatment for atypical acid fast infection. Arch Dermatol 1976;112:517-9.
174. Bonnet E, Debat-Zoguereh D, Petit N, Ravaux I, Gallais H. Clarithromycin: a potent agent against infections due to Mycobacterium marinum. Clin Infect Dis 1994;18:664-6.
175. Dylewsky JS, Zackon HM, Latour AH, Berry GR. Mycobacterium szulgai: an unusual pathogen. Rev Infect Dis 1987;9:578-80.
176. Gur H, Porat S, Hass H, Naparstek Y, Eliakim M. Disseminated mycobacterial disease caused by Mycobacterium szulgai. Arch Intern Med 1984;144:1861-3.
177. Cross GM, Guill MA, Aton JK. Cutaneous Mycobacterium szulgai infection. Arch Dermatol 1985;121:247-9.
178. Marks J, Jenkins PA, Tsukamura M. Mycobacterium szulgai - a new pathogen. Tubercle 1972;53:210-4.
179. Maloney JM, Gregg CR, Stephens DS, Manian FA, Rimland D. Infections caused by Mycobacterium szulgai in humans. Rev Infect Dis 1987;9:1120-6.
180. Davidson PT. Mycobacterium szulgai: a new pathogen causing infections in the lung. Chest 1976;69:799-801.
181. Good RC, Silcox VA, Kilburn JO, Plikyatis BD. Identification and drug susceptibility tests results for Mycohacterium spp. Clin Microbiol Newsl 1985;7:133-6.
182. Kanlikama M, Ozsahinoglu C, Akan E, Ozcan K. Mycobacterial species causing cervicofacial infection in Turkey. Eur Arch Otorhinolaryngol 1993;250:237-9.
183. Clancey JK. Mycobacterial skin ulcers in Uganda: description of a new mycobacterium (Mycobacterium buruli). J Pathol Biol 1964;88:175-87.
184. Fehr H, Egger M, Senn I. Cotrimoxazole in the treatment of Mycobacterium ulcerans infection (Buruli ulcer) in West Africa. Trop Doctor 1994;24:61-3.
185. Costrini A, D'Esopo N, Gross W, Hawkins J. Clinical and roentgenographic features of nosocomial infection due to Mycobacterium xenopi (abstract). Am Rev Respir Dis 1987;117(4 pt 2):418.
186. Sniadack DH, Ostroff SM, Karlix MA, Smithwick RW, Schwartz B, Sprauer MA, et al. A nosocomial pseudo-outbreak of Mycobacterium xenopi due to a contaminated potable water supply: lessons in prevention. Infect Control Hosp Epidemiol 1993;14:636-41.
187. Marks J, Schwabacher H. Infection due to Mycobacterium xenopi. Br Med J 1965;1:32-3.
188. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax 1984;39:376-82.
189. Papillon F, Grosset J, Mignon A, Parrot R, Truffot CH, Chretien J, GETIM. Combined chemotherapy with rifabutin for Mycobacterium xenopi respiratory disease in HIV-negative patients. Am Rev Respir Dis 1990;141:A614.
190. Tsukamura M. A group of mycobacteria from soil sources resembling nonphotochromogens (group 3): a description of Mycobacterium nonchromogenicum. Med Biol 1965;71:110-3.
191. Edwards MS, Huber TW, Baker CV. Mycobacterium terrae synovitis and osteomyelitis. Am Rev Respir Dis 1978;117:161-3.
192. Dechairo DC, Kittredge D, Meyers A, Corrales J. Septic arthritis due to Mycobacterium triviale. Am Rev Respir Dis 1973;108:1224-6.
193. Mehta JB, Hovis WM. Tenosynovitis of the forearm due to Mycobacterium terme (radish bacillus). South Med J 1983;76:1433-5.
194. Tsukamura M, Kita N, Otsuka W, Shimode H, A study of the taxonomy of the Mycobacterium nonchromogenicum complex and a report of six cases of lung infection due to Mycobacterium nonchromogenicum. Microbiol Immunol 1983;27:219-36.
195. Butler WR, O'Connor SP, Yakrus MA, Smithwick RW, Plikaytis BB, Moss CW, et al. Mycobacterium celatum sp. nov. Int J Syst Bacteriol 1993;43:539-48.
196. Piersimoni C, Tortoli E, DeSio G. Disseminated infection due to Mycobacterium celatum in patients with AIDS (letter). Lancet 1994;344:332.
197. Levy-Frebault V, Pangon B, Bure A, Katlama C, Marche C, David HL. Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol 1987;25:154-7.
198. Valdivia A, Mendez JS, Font ME. Mycobacterium habana: probable enueva especie dentro de las no classificadas. Bol Hig Epidemiol (Habana) 1971;9:65-73.
199. Lavy A, Yoshpe-Purer Y. Isolation of Mycobacterium simiae from clinical specimens in Israel. Tubercle 1992;63:279-85.